October 11, 2021
  • October 11, 2021
  • Home
  • Flagship product
  • BioHarvest Sciences Inc. launches direct-to-consumer sales of its flagship product VINIA in the United States through its website

BioHarvest Sciences Inc. launches direct-to-consumer sales of its flagship product VINIA in the United States through its website

By on May 12, 2021 0

VINIA is the first and only product in the world containing Piceid Resveratrol from red grapes at levels in each 400 mg capsule of VINIA equivalent to an average bottle of red wine, delivering the benefits of red wine with the benefit of zero calories, zero sugar and zero percent alcohol

BioHarvest Sciences Inc. (CSE: BHSC) (FRA: 8MV) has announced the launch of direct sales to consumers of its flagship product VINIA in the United States, through its vinia.com website.

After years of developing its BioFarming technology, the company said it is proud to launch the first product based on this technology in the US market. VINIA is the first and only product in the world containing Piceid Resveratrol from red grapes at levels in each 400 mg capsule of VINIA equivalent to an average bottle of red wine, delivering the benefits of red wine with the benefit of zero calorie, zero sugar and zero percent alcohol.

The Piceid Resveratrol contained in VINIA has the unique ability to be solubilized in the body and is 25 times more soluble than polygonum resveratrol, which is used in the nutraceutical industry today. Along with this solubility advantage, VINIA also has excellent bioavailability, entering blood plasma within 20 minutes and providing 12 hours of sustained release. As a result, VINIA demonstrates a unique ability to support heart health and improve physical energy and mental alertness, through increased blood flow and oxygen delivery to body tissues and organs.

READ: BioHarvest Sciences Achieves Record First Quarter Sales for Its Flagship Functional Food Product VINIA in Israel

BioHarvest said that the successful launch of VINIA in Israel has provided the company with experience in the important customer acquisition process and gives confidence in a successful launch of the product in the US market.

“This major event is the culmination of over 12 years of intensive R&D,” said Dr. Yochi Hagay, CTO of BioHarvest in a statement. “It is the realization of our vision to bring science-based nutraceuticals, with clinically proven benefits, to consumers. Today, it is the validation of the efforts of the R&D team which has relentlessly pursued the development of the BioFarming and VINIA technology.

“Most of the team members have been with the company for 12 years and not only celebrate the culmination of their efforts at such an important event, but actively apply the BioFarming platform to the development of new products, including new cannabis products. he added.

The company said the launch will encompass an integrated marketing mix that harnesses the power of a cohesive communications message across all major social platforms, including Facebook, YouTube, Google Search, and other online channels such as Taboola. He said a significant budget has been allocated to educate consumers over 40 of the uniqueness of VINIA and the health and wellness benefits it offers. In addition, the company plans to launch a massive public relations campaign targeting the demographics of its market.

The first phase of the launch will focus on the brand’s scientific credentials, communicate its superiority over other supplements, and highlight its ability to deliver multiple wellness benefits. The Ccmpany said it would lead the narrative and use VINIA to help educate U.S. consumers in the $ 53 billion dietary supplement market on the importance of validating the solubility, bioavailability and efficacy of supplements it has. they buy. It intends to make VINIA the Gold Standard in the nutraceutical market.

“I have imagined this exciting moment since I heard about BioHarvest 18 months ago,” said Ilan Sobel, CEO of BioHarvest. “I first became an investor in the company when I realized the potential of the BioFarming technology platform. When I took over as CEO almost a year ago, I focused the company’s efforts and resources on building a business platform and manufacturing capabilities in order to put the products based on BioFarming to market in an efficient and ultimately cost effective manner. We initially launched our products in Israel, so that we could test our capabilities. Our success in Israel may be a predictor for the US market. I I am optimistic about VINIA sales in the US and intend to provide revenue forecasts by mid-July 2021. ”

Based in Vancouver, British Columbia, Canada, BioHarvest Sciences is the developer and exclusive owner of the patented and patented BioFarming technology. It is the first and only plant cell technology on an industrial scale capable of producing the active plant ingredients without the need to grow the plant itself.

The company’s technology is GMO-free and has already been validated by VINIA. The company expects to generate significant revenue in the global nutraceutical ingredients and dietary supplement market with VINIA and other Super Fruit Nutraceutical products.

In addition, by adapting its technology to the cannabis plant and developing an adequate production capacity, BioHarvest Sciences’ goal is also to become a leading supplier of cannabis for legal medical and recreational purposes.

Contact the author at [email protected]


Source link

Leave a comment

Your email address will not be published. Required fields are marked *